NSEBSE
There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-
MARKET DEPTH

Total bid0.00
Total ask0.00
HIGH/LOW

LOW/HIGH
₹1,159.703 days ago
₹1,210.503 days ago

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
ICICI Pru India Opp Fund(G)
ICICI Pru Dividend Yield Equity Fund(G)
3Y Return+22.6%
NAV₹1,348.80

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.